NR4A2 and Dystonia with Dopa Responsiveness

Mov Disord. 2021 Sep;36(9):2203-2204. doi: 10.1002/mds.28701. Epub 2021 Jun 21.
No abstract available

Keywords: NR4A2; dopa response; dystonia; neurodevelopmental disorder.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Dystonia* / drug therapy
  • Dystonia* / genetics
  • Dystonic Disorders* / drug therapy
  • Dystonic Disorders* / genetics
  • Humans
  • Infant
  • Levodopa
  • Male
  • Nuclear Receptor Subfamily 4, Group A, Member 2 / genetics*

Substances

  • NR4A2 protein, human
  • Nuclear Receptor Subfamily 4, Group A, Member 2
  • Levodopa